IRCT2014092419255N3已完成4 期
Thoracoscopic sympathectomy assessed in patients with Hyperhidrosis training centers
The Deputy of Research and Technology of Babol University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 5 years 至 100 years(—)
- 性别
- All
入选标准
- •Inclusion Criteria: Patients who are five years and older; with bilateral hyperhidrosis in the armpits and hands; and written informed consent;
- •Exclusion criteria: Patients with hyperthyroidism; hypopituitarism; metabolic diseases (thyrotoxicosis; Diabetes mellitus; hypoglycemia; gout; pheochromocytoma; menopause); pregnancy; carcinoid syndrome; acromegaly; neurologic diseases (Parkinson’s disease; spinal cord injuries; cerebral vascular damage); malignancies (myeloproliferative disorders; Hodgkin's disease); febrile diseases; cardiovascular shock; heart failure; respiratory failure; alcohol poisoning (chronic alcoholism and drug abuse); signs of hanging down or depression; neuroplastic diseases; use of drugs and tuberculosis
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Single-port thoracoscopic sympathicotomy for treatment of complex regional pain syndrome type I, a feasibility study.posttraumatic dystrophyposttraumatic paindydrome1001498210009720NL-OMON36901niversitair Medisch Centrum Groningen20
已完成
不适用
Single-port thoracoscopic sympathicotomy for treatment of raynaud's phenomenon, a feasibility study.Raynaud's disease10047075NL-OMON46918niversitair Medisch Centrum Groningen10
已完成
4 期
Thoracoscopic Sympathectomy for BlushingFacial BlushingNCT00225069Odense University Hospital100
已完成
2 期
Transthoracoscopic Sympathectomy T-3 and T-4 in moderate palmar Hyperhidrosis .Palmar HyperhidrosisRPCEC00000154Minimal Access Surgery National Centre100
招募中
不适用
Prospective study of thoracoscopic esophagectomy with rigid and flexible video-endoscopeesophageal cancerJPRN-UMIN000011642Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences30
